It matters when you begin using hormone replacement therapy. The benefits only accrue if you start quickly after menopause, before you lose the receptors. Look at the numbers and decide which group you'd rather be in.
Women who take HRT for 10 years following menopause have a significantly reduced risk of mortality, heart failure and heart attack without any increased risk of cancer, DVT or stroke,...
A paper published in the BMJ Group's Journal of Family Planning and Reproductive Healthcare back in January cast doubt on the "unreliable" Million Women Study which associated HRT with an increased risk of breast cancer.
1006 women (504 in HRT group and 502 in non-HRT group) were included in the study...
After 10 years of randomised treatment the women were encouraged to discontinue the use of HRT... During this period, 26 women in the non-HRT group died and 33 died or experienced a cardiovascular end-point, compared to 15 deaths and 16 deaths or cardiovascular end-points in the HRT group.
The women were followed for another six years. During this time, the primary end-point was seen in 53 women in the non-HRT group (40 deaths, eight heart failures and five heart attacks) and 33 in the HRT group (27 deaths, three heart failures and three heart attacks).